INCR (Intercure Ltd. Ordinary Shares) Stock Analysis - Analyst Ratings

Intercure Ltd. Ordinary Shares (INCR) is a publicly traded Healthcare sector company. As of May 21, 2026, INCR trades at $0.84 with a market cap of $44.84M and a P/E ratio of -0.47. INCR moved +0.00% today. Year to date, INCR is -17.79%; over the trailing twelve months it is -46.56%. Its 52-week range spans $0.68 to $2.01. Rallies surfaces INCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate INCR?

The average price target is $0.00.

INCR Key Metrics

Key financial metrics for INCR
MetricValue
Price$0.84
Market Cap$44.84M
P/E Ratio-0.47
EPS$-1.85
Dividend Yield0.00%
52-Week High$2.01
52-Week Low$0.68
Volume2
Avg Volume0
Revenue (TTM)$2.67B
Net Income$-138.47M
Gross Margin53.89%

INCR Analyst Consensus

INCR analyst coverage data. Average price target: $0.00.

Latest INCR News

Recent INCR Insider Trades

  • Gaenzle Christopher L sold 4.68K (~$255.43K) on Sep 18, 2017.
  • Rush Gregory S sold 9.70K (~$528.60K) on Sep 18, 2017.
  • Macdonald Alistair sold 2.35K (~$128.20K) on Sep 18, 2017.

Common questions about INCR

What do analysts rate INCR?
The average price target is $0.00.
Does Rallies show INCR price targets?
Yes. Rallies tracks INCR analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is INCR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INCR. It does not provide personalized investment advice.
INCR

INCR